Mid-South REACH Hub to speed biomedical innovation in colleges
Official title: Mid-South REACH Hub
Funded at Vanderbilt University · NIH-11411322 · Data updated 2026-11-12
A multi-state program to help two-year colleges turn biomedical discoveries into real-world products by providing education, mentorship, and funding.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project start | September 25, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $969,873 |
| NIH project number | 5U01GM152538-04 |
| Project ID | NIH-11411322 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are students, researchers, clinicians, or entrepreneurs at participating colleges who have a biomedical idea with potential to improve health and want mentorship and funding to translate it.
✕Less likely to help
Patients not involved in or connected to the participating institutions may not directly benefit from this hub.
What this research studies
This project creates a four-state REACH Hub hosted by Vanderbilt University to speed up the translation of biomedical ideas from colleges into practical health solutions. It connects hundreds of colleges and universities, offering education, mentorship, and funds to aspiring biomedical entrepreneurs. The hub emphasizes scalable collaboration and leverages state and institutional matching funds to support innovators within their own communities. The goal is to build a local medical-innovation economy that improves human health across the region.
Why it matters
Potential benefit: If successful, patients could benefit from faster development of new biomedical technologies and therapies arising from regional academic innovations.
How similar studies have gone: Regional innovation hubs have shown that structured support can accelerate product development and collaboration across institutions.
Where this research is happening
-
Vanderbilt University
Nashville, United States Active
Researchers
- Principal investigator: Webster, Robert James — Vanderbilt University
- Study coordinator: Webster, Robert James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.